Christian Antoni, MD, Friedrich-Alexander University, Erlangen, Germany; Gerald Krueger, MD, University of Utah Health Services Center, Salt Lake City, UT, United States; Anna Beutler, MD, Centocor, Inc., Malvern, PA, United States; Arthur Kavanaugh, MD, University of California, San Diego, La Jolla, CA, United StatesLe texte complet de cet article est disponible en PDF.
Dr. Antoni is an investigator and consultant for infliximab at Centocor. Dr. Krueger is a consultant to Biogen, Genentech, and Centecor;. on the sponsored speakers list for Amgen, Biogen, Genentech, and Centecor; and has participated in clinical trials for each of these companies. Neither Dr. Krueger nor his family owns stock in these companies.
Studies have been funded by a research grant from Centocor (IMPACT) or have been done by Centocor (IMPACT 2).